ASHLEY PERREAULT: Open Payments
NPI 1033699509 · KANKAKEE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,157 in 56 payments from 17 companies in 2025. Trend: 2023 $1,283 · 2024 $1,551 · 2025 $1,157
Food & beverage: $1,157
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $160 |
| PFIZER INC. | 7 | $144 |
| E.R. Squibb & Sons, L.L.C. | 5 | $141 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $95 |
| Merck Sharp & Dohme LLC | 5 | $88 |
| Boston Scientific Corporation | 3 | $85 |
| AstraZeneca Pharmaceuticals LP | 5 | $84 |
| Alnylam Pharmaceuticals Inc. | 4 | $75 |
| BridgeBio Pharma, Inc. | 2 | $48 |
| Regeneron Healthcare Solutions, Inc. | 3 | $47 |
Products named: Wegovy, ELIQUIS, VYNDAQEL, JARDIANCE, VERQUVO, WATCHMAN FLX, FARXIGA, CAMZYOS.
Industry payments across IL — which companies pay providers there.
